BeiGene
BGNE
#983
Rank
$19.60 B
Marketcap
$172.85
Share price
1.06%
Change (1 day)
-25.17%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yields for this company